Lupus treatment hope from Japanese miRNA research
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportA group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
AbbVie and Anima Biotech have announced a collaboration to discover and develop mRNA biology modulators…
BioNTech SE has signed a memorandum of understanding (MoU) with the Government of the United…
Each month here at Labiotech.eu, we produce a special newsletter. While still news-related, these special…
Ethris GmbH is to collaborate with U.K.-based DIOSynVax to jointly develop a protective mRNA vaccine…
Providence Therapeutics Holdings Inc. says its new mRNA vaccine program for rabies post-exposure prophylaxis has…
ExPLoRNA Therapeutics, a Polish biotech company working on mRNA vaccines and therapeutics, has received funding…
With the help of artificial intelligence (AI), researchers at Chalmers University of Technology in Sweden…
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working…
RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technology platform company, and the Agency for…
Nutcracker Therapeutics, Inc. has presented the first set of preclinical data for its lead oncology…